J.G.Chemicals Ltd
NSE: JGCHEMBSE: 544138
₹ 556.00▼ 7.9 (−1.4%)28 Oct, 03:29 pm IST
- P/E
- 29x
- 52-week range
- 298.4 – 694.9
- ROE
- 13%
- ROCE
- 18%
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →J.G.Chemicals Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)29 against a typical 22.7: pricier than most peers (1st = cheapest).41st of 72
- Sales growth+45% against a typical +12.7% from a year earlier.13th of 65
- Profit growth+62.5% against a typical +13.6% from a year earlier.14th of 49
- Share price, 3 months+10.6% against a typical −2.2%.15th of 65
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A+ to A by 2 agenciesA
DefaultRiskyModerateSafeVery safe
- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A+ | Stable | 25 Sep 2026 |
| CRISIL | Crisil A | Stable | 14 Nov 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 25 Sep 2026 | New rating | CARE A+ | — | CARE | ₹ 19.75 Cr. | |
| 14 Nov 2025 | Reaffirmed | Crisil A | — | CRISIL | ₹ 60 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 14 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 11 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 27 Jun 2025 | Dividend | To Recommend dividend |
| 17 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 153 | 161 | 181 | 203 | 212 | 209 | 224 | 218 | 220 | 248 | 286 | 316 |
| Expenses | 145 | 147 | 164 | 180 | 191 | 186 | 205 | 198 | 202 | 226 | 265 | 282 |
| Operating Profit | 8 | 15 | 17 | 22 | 21 | 23 | 19 | 20 | 18 | 23 | 21 | 34 |
| OPM % | 5% | 9% | 9% | 11% | 10% | 11% | 9% | 9% | 8% | 9% | 8% | 11% |
| Other Income | −1 | 2 | 3 | 0 | 3 | 3 | 4 | 3 | 4 | 3 | 5 | 3 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 15 | 18 | 21 | 23 | 24 | 22 | 22 | 20 | 25 | 25 | 35 |
| Tax % | 22% | 28% | 25% | 25% | 26% | 26% | 26% | 25% | 26% | 25% | 26% | 25% |
| Net Profit | 4 | 11 | 14 | 16 | 17 | 18 | 16 | 16 | 15 | 18 | 19 | 26 |
| EPS in Rs | 1.18 | 3.22 | 3.34 | 3.88 | 4.21 | 4.33 | 3.92 | 4.02 | 3.67 | 4.47 | 4.65 | 6.4 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- 18%
- 3 Years
- 8%
- TTM
- 24%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- 24%
- 3 Years
- 7%
- TTM
- 16%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
Return on Equity
- 10 Years
- —
- 5 Years
- 16%
- 3 Years
- 13%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 29xEPS (12 months) ₹ 19.19Median P/E 24.8x
P/E (times)EPS (₹)
Prices are delayed and for information only. Nothing on this page is investment advice.